RecruitingNCT07425730
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Myocardial Dysfunction in Pediatric Lupus
Sponsor
Shanghai Jiao Tong University School of Medicine
Enrollment
60 participants
Start Date
Feb 1, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.
Eligibility
Min Age: 7 YearsMax Age: 17 Years
Inclusion Criteria2
- fulfill the American College of Rheumatology (ACR) criteria
- disease onset at ages before 18 years
Exclusion Criteria2
- patients with a history of concomitant malignancy
- patients with active bacterial, viral, fungal, mycobacterial infection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07425730
Related Trials
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT0630897818 locations
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT0717528554 locations
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT073324813 locations
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
NCT063142826 locations
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
NCT070879122 locations